BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 23963877)

  • 1. The cumulative risk of false-positive results in the Norwegian Breast Cancer Screening Program: updated results.
    Roman M; Hubbard RA; Sebuodegard S; Miglioretti DL; Castells X; Hofvind S
    Cancer; 2013 Nov; 119(22):3952-8. PubMed ID: 23963877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The cumulative risk of a false-positive recall in the Norwegian Breast Cancer Screening Program.
    Hofvind S; Thoresen S; Tretli S
    Cancer; 2004 Oct; 101(7):1501-7. PubMed ID: 15378474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The cumulative risk of false-positive screening results across screening centres in the Norwegian Breast Cancer Screening Program.
    Roman M; Skaane P; Hofvind S
    Eur J Radiol; 2014 Sep; 83(9):1639-44. PubMed ID: 24972452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cumulative risk of a false-positive screening result: A retrospective cohort study using empirical data from 10 biennial screening rounds in BreastScreen Norway.
    Tsuruda KM; Larsen M; Román M; Hofvind S
    Cancer; 2022 Apr; 128(7):1373-1380. PubMed ID: 34931707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Breast cancer detection risk in screening mammography after a false-positive result.
    Castells X; Román M; Romero A; Blanch J; Zubizarreta R; Ascunce N; Salas D; Burón A; Sala M;
    Cancer Epidemiol; 2013 Feb; 37(1):85-90. PubMed ID: 23142338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interval Breast Cancer Rates and Histopathologic Tumor Characteristics after False-Positive Findings at Mammography in a Population-based Screening Program.
    Hofvind S; Sagstad S; Sebuødegård S; Chen Y; Roman M; Lee CI
    Radiology; 2018 Apr; 287(1):58-67. PubMed ID: 29239711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cumulative probability of false-positive recall or biopsy recommendation after 10 years of screening mammography: a cohort study.
    Hubbard RA; Kerlikowske K; Flowers CI; Yankaskas BC; Zhu W; Miglioretti DL
    Ann Intern Med; 2011 Oct; 155(8):481-92. PubMed ID: 22007042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ten-year risk of false positive screening mammograms and clinical breast examinations.
    Elmore JG; Barton MB; Moceri VM; Polk S; Arena PJ; Fletcher SW
    N Engl J Med; 1998 Apr; 338(16):1089-96. PubMed ID: 9545356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of Breast Cancer in Women with False-Positive Results according to Mammographic Features.
    Castells X; Torá-Rocamora I; Posso M; Román M; Vernet-Tomas M; Rodríguez-Arana A; Domingo L; Vidal C; Baré M; Ferrer J; Quintana MJ; Sánchez M; Natal C; Espinàs JA; Saladié F; Sala M;
    Radiology; 2016 Aug; 280(2):379-86. PubMed ID: 26878225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toward the breast screening balance sheet: cumulative risk of false positives for annual versus biennial mammograms commencing at age 40 or 50.
    Winch CJ; Sherman KA; Boyages J
    Breast Cancer Res Treat; 2015 Jan; 149(1):211-21. PubMed ID: 25476499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and radiological features of breast tumors according to history of false-positive results in mammography screening.
    Domingo L; Romero A; Blanch J; Salas D; Sánchez M; Rodríguez-Arana A; Ferrer J; Ibáñez J; Vega A; Laso MS; Castells X; Sala M
    Cancer Epidemiol; 2013 Oct; 37(5):660-5. PubMed ID: 23962702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cumulative Probability of False-Positive Results After 10 Years of Screening With Digital Breast Tomosynthesis vs Digital Mammography.
    Ho TH; Bissell MCS; Kerlikowske K; Hubbard RA; Sprague BL; Lee CI; Tice JA; Tosteson ANA; Miglioretti DL
    JAMA Netw Open; 2022 Mar; 5(3):e222440. PubMed ID: 35333365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. False-positive results in mammographic screening for breast cancer in Europe: a literature review and survey of service screening programmes.
    Hofvind S; Ponti A; Patnick J; Ascunce N; Njor S; Broeders M; Giordano L; Frigerio A; Törnberg S; ; Van Hal G; Martens P; Májek O; Danes J; von Euler-Chelpin M; Aasmaa A; Anttila A; Becker N; Péntek Z; Budai A; Mádai S; Fitzpatrick P; Mooney T; Zappa M; Ventura L; Scharpantgen A; Hofvind S; Seroczynski P; Morais A; Rodrigues V; Bento MJ; Gomes de Carvalho J; Natal C; Prieto M; Sánchez-Contador Escudero C; Zubizarreta Alberti R; Fernández Llanes SB; Ascunce N; Ederra Sanza M; Sarriugarte Irigoien G; Salas Trejo D; Ibáñez Cabanell J; Wiege M; Ohlsson G; Törnberg S; Korzeniewska M; de Wolf C; Fracheboud J; Patnick J; Lancucki L; Ducarroz S; Suonio E
    J Med Screen; 2012; 19 Suppl 1():57-66. PubMed ID: 22972811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mammographic screening interval in relation to tumor characteristics and false-positive risk by race/ethnicity and age.
    O'Meara ES; Zhu W; Hubbard RA; Braithwaite D; Kerlikowske K; Dittus KL; Geller B; Wernli KJ; Miglioretti DL
    Cancer; 2013 Nov; 119(22):3959-67. PubMed ID: 24037812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Benefits and Harms of Breast Cancer Screening: A Systematic Review.
    Myers ER; Moorman P; Gierisch JM; Havrilesky LJ; Grimm LJ; Ghate S; Davidson B; Mongtomery RC; Crowley MJ; McCrory DC; Kendrick A; Sanders GD
    JAMA; 2015 Oct; 314(15):1615-34. PubMed ID: 26501537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cumulative false positive recall rate and association with participant related factors in a population based breast cancer screening programme.
    Castells X; Molins E; Macià F
    J Epidemiol Community Health; 2006 Apr; 60(4):316-21. PubMed ID: 16537348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The risk of radiation-induced breast cancers due to biennial mammographic screening in women aged 50-69 years is minimal.
    Hauge IH; Pedersen K; Olerud HM; Hole EO; Hofvind S
    Acta Radiol; 2014 Dec; 55(10):1174-9. PubMed ID: 24311702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Likelihood of early detection of breast cancer in relation to false-positive risk in life-time mammographic screening: population-based cohort study.
    Otten JDM; Fracheboud J; den Heeten GJ; Otto SJ; Holland R; de Koning HJ; Broeders MJM; Verbeek ALM
    Ann Oncol; 2013 Oct; 24(10):2501-2506. PubMed ID: 23788759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of mammography screening interval on breast cancer diagnosis by menopausal status and BMI.
    Dittus K; Geller B; Weaver DL; Kerlikowske K; Zhu W; Hubbard R; Braithwaite D; O'Meara ES; Miglioretti DL;
    J Gen Intern Med; 2013 Nov; 28(11):1454-62. PubMed ID: 23760741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of breast cancer after false-positive test results in screening mammography.
    von Euler-Chelpin M; Risør LM; Thorsted BL; Vejborg I
    J Natl Cancer Inst; 2012 May; 104(9):682-9. PubMed ID: 22491228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.